Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESPAC-3: Adjuvant Chemotherapy in Resected Pancreatic Cancer
NCT00058201Phase 3Completed
- Sponsor
- Royal Liverpool University Hospital
- Start
- Jul 2001
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 3 trial of gemcitabine, fluorouracil in pancreatic cancer (PC), sponsored by Royal Liverpool University Hospital. Started Jul 2001; status: completed.
02
Drugs
gemcitabinefluorouracil
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00058201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00058201.